Stock AnalizClorox (CLX) earnings for the quarter ended September 2026: EPS beats estimates
Clorox reported results for the quarter ended September 2026 on November 2, 2026. Adjusted earnings per share came in at $1.55 against the analysts’ average forecast of $1.07, a beat of 45.2%.
Revenue for the quarter was $1.91 billion, up 33.3% from $1.43 billion in the same quarter a year earlier.
The market’s verdict: the stock rose 6.6% on the first trading day after the report.
The last four quarters
Clorox has beaten the analysts’ EPS forecast in 3 of the last 4 quarters.
| Quarter | EPS | Forecast | Surprise | Revenue growth | Price reaction |
|---|---|---|---|---|---|
| Sep 2026 | $1.55 | $1.07 | +45.2% | +33% | +6.6% |
| Jun 2026 | $1.66 | $1.65 | +0.9% | — | +9.6% |
| Mar 2026 | $1.64 | $1.54 | +6.2% | +0% | −8.1% |
| Dec 2025 | $1.39 | $1.43 | −3.0% | −1% | +4.0% |
What comes next
Analysts expect EPS of $0.98 for the next quarter on average and $5.72 for the fiscal year ending June 30, 2027.
The average analyst price target is $97.00, 11% below the current price of $109.46.
Valuation and score
Clorox scores 2.0 out of 5 overall on Stock Analiz (average), trades at a trailing P/E of about 19.7, and its intrinsic value under moderate assumptions is about 24% below the current market value. Full Clorox analysis with 10 years of financials
Frequently asked questions
What was Clorox’s EPS for the quarter ended September 2026?
$1.55 adjusted per share, against an analyst consensus of $1.07.
How much revenue did Clorox report?
$1.91 billion, up 33.3% year over year.
More
This report was written automatically from the published numbers within hours of the release. It is information, not investment advice.